Fast Market Research

OTC Pharmaceuticals - North America (NAFTA) Industry Guide: New Research Report Available at Fast Market Research

Fast Market Research recommends "OTC Pharmaceuticals - North America (NAFTA) Industry Guide" from MarketLine, now available


Boston, MA -- (SBWIRE) -- 10/08/2013 -- Introduction

The NAFTA OTC Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market share, market size (value 2008-12, and forecast to 2017). The guide also contains descriptions of the leading companies including key financial metrics and analysis of competitive pressures within the market.

Features and benefits

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the NAFTA market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the NAFTA OTC pharmaceuticals market
- Leading company profiles reveal details of key OTC pharmaceuticals players' NAFTA operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the NAFTA OTC pharmaceuticals market with five year forecasts
- Compares data from the US, Canada and Mexico, alongside individual chapters on each country

View Full Report Details and Table of Contents


The North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in North America: the US, Canada and Mexico. The OTC pharmaceuticals industry within the NAFTA countries had a total market value of $34,302.5 million in 2012.The Mexico was the fastest growing country, with a CAGR of 5.4% over the 2008-12 period.
Within the OTC pharmaceuticals industry, the US is the leading country among the NAFTA bloc, with market revenues of $28,784.9 million in 2012. This was followed by Canada and Mexico, with a value of $3,177.1 and $2,340.5 million, respectively.
The US is expected to lead the OTC pharmaceuticals industry in the NAFTA bloc, with a value of $32,123.7 million in 2017, followed by Canada and Mexico with expected values of $3,645.7 and $2,835.0 million, respectively.

Your key questions answered

- What was the size of the NAFTA OTC pharmaceuticals market by value in 2012?
- What will be the size of the NAFTA OTC pharmaceuticals market in 2017?
- What factors are affecting the strength of competition in the NAFTA OTC pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the NAFTA OTC pharmaceuticals market?

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Pharmaceuticals - North America (NAFTA) Industry Guide
- OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide
- OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide
- OTC Pharmaceuticals - Scandinavia Industry Guide
- Water Utilities - North America (NAFTA) Industry Guide
- Automotive Manufacturing - North America (NAFTA) Industry Guide
- Forest Products - North America (NAFTA) Industry Guide
- Utilities - North America (NAFTA) Industry Guide
- Nuclear Energy - North America (NAFTA) Industry Guide
- Car Manufacturing - North America (NAFTA) Industry Guide